COVID-19, caused by the SARS-CoV-2 virus, is a highly contagious respiratory disease that has dramatically impacted global health. Symptoms of COVID-19 vary widely, from mild conditions like fever and cough to severe respiratory issues and loss of taste or smell. The virus spreads primarily through respiratory droplets and small airborne particles, making rapid and accurate detection crucial in managing and controlling its spread, especially with the emergence of various variants.

In today’s healthcare environment, the iGenesis SARS-CoV-2 (COVID-19) Nucleic Acid Detection Cartridge is an essential tool for accurately identifying SARS-CoV-2, including key variants such as Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2), and Omicron (B.1.1.529). This real-time reverse transcription PCR (RT-PCR) test is designed to detect these variants with high precision, ensuring no off-target results or missed detections, even for multi-mutant strains.

The iCassette uses a magnetic bead transfer structure and process technology, as well as a material distributed mixing device structure. It is compatible with the Galaxy: Nano, Lite and Pro. The test can be performed on demand with no minimum batch size requirement, which is advantageous for clinics and hospitals that require rapid results. The fully automated sample magnetic beads extraction to qPCR process provides results in one and a half hours with minimal hands-on time, increasing laboratory efficiency and reducing patient waiting times.

The SARS-CoV-2/Flu A/Flu B/RSV Diagnostic Panel is suitable for use with oropharyngeal swab, nasopharyngeal swab, or sputum covering a wide range of clinical scenarios. It is stored at 2-8°C and includes internal process control to ensure the accuracy and reliability of each test performed.

This kit is an ideal choice for healthcare facilities seeking a reliable, efficient, and cost-effective solution for detecting SARS-CoV-2 and its variants.